Abstract
Transcatheter aortic valve implantation (TAVI), or replacement (TAVR), has become a cornerstone in the treatment of aortic stenosis, and aortic regurgitation. TAVI, a minimally invasive procedure for replacing a stenosed aortic valve, has established itself as a cornerstone therapy for high-surgical-risk patients with aortic stenosis (AS). However, the landscape is rapidly evolving, with growing interest in its application for intermediate and low-risk patients.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
